| NDC Code | 70934-514-30 |
|---|
| Package Description | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-514-30) |
|---|
| Product NDC | 70934-514 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Amlodipine And Benazepril Hydrochloride |
|---|
| Non-Proprietary Name | Amlodipine And Benazepril Hydrochloride |
|---|
| Dosage Form | CAPSULE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20200128 |
|---|
| End Marketing Date | 20231231 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA202239 |
|---|
| Manufacturer | Denton Pharma, Inc. DBA Northwind Pharmaceuticals |
|---|
| Substance Name | AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE |
|---|
| Strength | 10; 20 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS] |
|---|